Literature DB >> 21963581

A multifaceted program for improving quality of care in intensive care units: IATROREF study.

Maite Garrouste-Orgeas1, Lilia Soufir, Alexis Tabah, Carole Schwebel, Aurelien Vesin, Christophe Adrie, Marie Thuong, Jean Francois Timsit.   

Abstract

OBJECTIVE: To test the effects of three multifaceted safety programs designed to decrease insulin administration errors, anticoagulant prescription and administration errors, and errors leading to accidental removal of endotracheal tubes and central venous catheters, respectively. Medical errors and adverse events are associated with increased mortality in intensive care patients, indicating an urgent need for prevention programs.
DESIGN: Multicenter cluster-randomized study.
SETTING: One medical intensive care unit in a university hospital and two medical-surgical intensive care units in community hospitals belonging to the Outcomerea Study Group. PATIENTS: Consecutive patients >18 yrs admitted from January 2007 to January 2008 to the intensive care units.
INTERVENTIONS: We tested three multifaceted safety programs vs. standard care in random order, each over 2.5 months, after a 1.5-month observation period.
MEASUREMENTS AND MAIN RESULTS: Incidence rates of medical errors/1000 patient-days in the multifaceted safety program and standard-care groups were compared using adjusted hierarchical models. In 2117 patients with 15,014 patient-days, 8520 medical errors (567.5/1000 patient-days) were reported, including 1438 adverse events (16.9%, 95.8/1000 patient-days). The insulin multifaceted safety program significantly decreased errors during implementation (risk ratio 0.65; 95% confidence interval [CI] 0.52-0.82; p = .0003) and after implementation (risk ratio 0.51; 95% CI 0.35-0.73; p = .0004). A significant Hawthorne effect was found. The accidental tube/catheter removal multifaceted safety program decreased errors significantly during implementation (odds ratio [OR] 0.34; 95% CI 0.15-0.81; p = .01]) and nonsignificantly after implementation (OR 1.65; 95% CI 0.78-3.48). The anticoagulation multifaceted safety program was not significantly effective (OR 0.64; 95% CI 0.26-1.59) but produced a significant Hawthorne effect.
CONCLUSIONS: A multifaceted program was effective in preventing insulin errors and accidental tube/catheter removal. Significant Hawthorne effects occurred, emphasizing the need for appropriately designed studies before definitively implementing strategies. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00461461.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21963581     DOI: 10.1097/CCM.0b013e318232d94d

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  17 in total

1.  Understanding medical errors and adverse events in ICU patients.

Authors:  Maité Garrouste-Orgeas; Hans Flaatten; Rui Moreno
Journal:  Intensive Care Med       Date:  2015-08-07       Impact factor: 17.440

2.  Impact of contact isolation for multidrug-resistant organisms on the occurrence of medical errors and adverse events.

Authors:  J R Zahar; M Garrouste-Orgeas; A Vesin; C Schwebel; A Bonadona; F Philippart; C Ara-Somohano; B Misset; J F Timsit
Journal:  Intensive Care Med       Date:  2013-08-31       Impact factor: 17.440

3.  What's new for patient safety in the ICU?

Authors:  Maité Garrouste-Orgeas; Andreas Valentin
Journal:  Intensive Care Med       Date:  2013-07-09       Impact factor: 17.440

4.  Effect of a quality improvement program on weaning from mechanical ventilation: a cluster randomized trial.

Authors:  Bo Zhu; Zhiqiang Li; Li Jiang; Bin Du; Qi Jiang; Meiping Wang; Ran Lou; Xiuming Xi
Journal:  Intensive Care Med       Date:  2015-07-09       Impact factor: 17.440

5.  Effect of a multifaceted educational intervention for anti-infectious measures on sepsis mortality: a cluster randomized trial.

Authors:  Frank Bloos; Hendrik Rüddel; Daniel Thomas-Rüddel; Daniel Schwarzkopf; Christine Pausch; Stephan Harbarth; Torsten Schreiber; Matthias Gründling; John Marshall; Philipp Simon; Mitchell M Levy; Manfred Weiss; Andreas Weyland; Herwig Gerlach; Tobias Schürholz; Christoph Engel; Claudia Matthäus-Krämer; Christian Scheer; Friedhelm Bach; Reimer Riessen; Bernhard Poidinger; Karin Dey; Norbert Weiler; Andreas Meier-Hellmann; Helene H Häberle; Gabriele Wöbker; Udo X Kaisers; Konrad Reinhart
Journal:  Intensive Care Med       Date:  2017-05-02       Impact factor: 17.440

6.  Implementation of a CKD checklist for primary care providers.

Authors:  Mallika L Mendu; Louise I Schneider; Ayal A Aizer; Karandeep Singh; David E Leaf; Thomas H Lee; Sushrut S Waikar
Journal:  Clin J Am Soc Nephrol       Date:  2014-08-18       Impact factor: 8.237

7.  Systematic review of interventions to improve safety and quality of anticoagulant prescribing for therapeutic indications for hospital inpatients.

Authors:  Andrew Frazer; James Rowland; Alison Mudge; Michael Barras; Jennifer Martin; Peter Donovan
Journal:  Eur J Clin Pharmacol       Date:  2019-09-11       Impact factor: 2.953

8.  Impact of organizational culture on preventability assessment of selected adverse events in the ICU: evaluation of morbidity and mortality conferences.

Authors:  Iris Pelieu; Juliette Djadi-Prat; Silla M Consoli; Alain Cariou; Bertrand Guidet; Cécile You-Harada; Virginie Paget; Guillaume Héraud; Claire Lefur; Adeline Massin; Marlène Hennequin; Pierre Durieux; Jean-Yves Fagon; Christophe Faisy
Journal:  Intensive Care Med       Date:  2013-04-12       Impact factor: 17.440

9.  Using Incentives to Improve Resource Utilization: A Quasi-Experimental Evaluation of an ICU Quality Improvement Program.

Authors:  David J Murphy; Peter F Lyu; Sara R Gregg; Greg S Martin; Jason M Hockenberry; Craig M Coopersmith; Michael Sterling; Timothy G Buchman; Jonathan Sevransky
Journal:  Crit Care Med       Date:  2016-01       Impact factor: 7.598

10.  Mortality Among Older Adults Before Versus After Hospital Transition to Intensivist Staffing.

Authors:  Myura Nagendran; Justin B Dimick; Andrew A Gonzalez; John D Birkmeyer; Amir A Ghaferi
Journal:  Med Care       Date:  2016-01       Impact factor: 2.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.